The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTP ICAP Regulatory News (TCAP)

Share Price Information for TP ICAP (TCAP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 211.00
Bid: 209.00
Ask: 209.50
Change: 0.00 (0.00%)
Spread: 0.50 (0.239%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 211.00
TCAP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of Tender Offer

24 May 2019 10:38

RNS Number : 1414A
TP ICAP PLC
24 May 2019
 

TP ICAP plc announces the results of its Tender Offer in respect of its

£500,000,000 5.250 per cent. Notes due 2024 (ISIN: XS1555815494)

24 May 2019. On 16 May 2019, TP ICAP plc (the Company) announced an invitation to eligible holders of its outstanding £500,000,000 5.250 per cent. Notes due 2024 (ISIN: XS1555815494) (the Notes) to tender their Notes for purchase by the Company for cash up to the Maximum Acceptance Amount, subject to satisfaction of the New Financing Condition (the Offer).

The Offer was made on the terms and subject to the conditions contained in a tender offer memorandum dated 16 May 2019 (the Tender Offer Memorandum) prepared by the Company, and subject to the offer restrictions set out in the Tender Offer Memorandum. Capitalised terms used in this announcement but not defined have the meanings given to them in the Tender Offer Memorandum.

The expiration deadline for the Offer was 4.00 p.m. (London time) on 23 May 2019. The Company now announces the results of the Offer.

Results of the Offer

The Company is pleased to announce that, conditional upon the satisfaction or waiver of the New Financing Condition, it will accept £68,625,000 in aggregate principal amount of Notes validly tendered in the Tender Offer. The pricing and acceptance of the Tender Offer is as follows:

Descriptionof the Notes

ISIN /

Common Code

Aggregate Principal Amount accepted for purchase

Scaling Factor

Purchase Price

Aggregate Principal Amount outstanding after the Settlement Date

£500,000,000 5.250 per cent. Notes due 2024

XS1555815494 / 155581549

£68,625,000

No scaling will be applied

104.00 per cent.

£431,375,000

All Notes purchased by the Company will be cancelled and will not be reissued or resold. Notes which have not been successfully submitted and accepted for purchase pursuant to the Tender Offer will remain outstanding after the Settlement Date.

The Settlement Date for the Offer (subject to the satisfaction or waiver of the New Financing Condition) is expected to be 30 May 2019.

The New Financing Condition will be satisfied upon the successful completion (in the sole determination of the Company) of the issue of the New Notes. The completion of the issue of the New Notes (and, accordingly, satisfaction of the New Financing Condition) is currently expected to occur on 29 May 2019.

Contact Information

DEALER MANAGER

Merrill Lynch International

2 King Edward Street

London EC1A 1HQ

United Kingdom

Telephone: +44 20 7996 5420

Attention: Liability Management Group

Email: DG.LM_EMEA@baml.com

TENDER AND INFORMATION AGENT

Lucid Issuer Services Limited

Tankerton Works

12 Argyle Walk

London WC1H 8HA

United Kingdom

Telephone: +44 20 7704 0880

Attention: David Shilson

Email: tpicap@lucid-is.com

 

MARKET ABUSE REGULATION

This announcement is released by TP ICAP plc and contains information that qualified or may have qualified as inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 (MAR), encompassing information relating to the Offer and proposed new issue of Notes described above. For the purposes of MAR and Article 2 of Commission Implementing Regulation (EU) 2016/1055, this announcement is made by Robin Stewart, Chief Financial Officer of TP ICAP plc.

DISCLAIMER This announcement must be read in conjunction with the Tender Offer Memorandum. The Offer has now expired.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
RTESEISULFUSEDI
Date   Source Headline
10th Aug 20227:00 amRNSHalf-year Report
28th Jul 20225:22 pmRNSResult of External Audit Tender
30th Jun 20225:44 pmRNSHolding(s) in Company
27th May 20223:30 pmRNSDirector/PDMR Shareholding
11th May 20226:01 pmRNSResult of AGM
11th May 20227:00 amRNSTrading Statement
4th May 20224:27 pmRNSGrant of Options and Director/PDMR Shareholding
22nd Apr 20224:49 pmRNSHolding(s) in Company
11th Apr 20224:17 pmRNSHolding(s) in Company
5th Apr 202211:02 amRNSAnnual Financial Report
4th Apr 20224:03 pmRNSDirector/PDMR Shareholding
31st Mar 20226:03 pmRNSDirector/PDMR Shareholding
29th Mar 20225:44 pmRNSHolding(s) in Company
15th Mar 20227:00 amRNSFinal Results
11th Jan 202211:35 amRNSHolding(s) in Company
22nd Dec 20215:00 pmRNSAppointment of new director
13th Dec 20213:24 pmRNSDirector/PDMR Shareholding
12th Nov 20212:04 pmRNSShareholder meeting update and PDMR transactions
12th Nov 20211:57 pmRNSTotal Voting Rights
2nd Nov 20217:00 amRNSTrading update - three months ended 30/09/2021
11th Oct 20214:00 pmRNSDirector/PDMR Shareholding
11th Oct 20213:01 pmRNSParameta Solutions Investor Seminar
7th Oct 202110:40 amRNSDirector/PDMR Shareholding
20th Sep 20214:58 pmRNSDirector/PDMR Shareholding
8th Sep 20215:08 pmRNSDirector/PDMR Shareholding
7th Sep 20217:00 amRNSHalf-year Report
3rd Aug 20217:00 amRNSTrading Statement
22nd Jun 20214:36 pmRNSDirector/PDMR Shareholding
18th May 202111:20 amRNSDirector/PDMR Shareholding
12th May 20215:49 pmRNSResult of AGM
12th May 20217:00 amRNSTrading Statement
23rd Apr 20215:10 pmRNSGrant of Options and Director/PDMR Shareholding
6th Apr 20214:32 pmRNSDirector/PDMR Shareholding - Replacement
1st Apr 20216:15 pmRNSDirector/PDMR Shareholding
26th Mar 20212:05 pmRNSAnnual Financial Report
10th Mar 20215:16 pmRNSRe-registration and name change
9th Mar 20217:03 amRNSFinal Results
26th Feb 20218:24 amRNSScheme Effective and Admission
24th Feb 20214:24 pmRNSCourt Sanction of the Scheme of Arrangement
18th Feb 20214:20 pmRNSHolding(s) in Company
17th Feb 20214:00 pmRNSDirector/PDMR Shareholding
17th Feb 20214:00 pmRNSTotal Voting Rights
17th Feb 202111:12 amRNSResults of Rump Placing
17th Feb 20217:00 amRNSResults of Rights Issue
16th Feb 20212:56 pmRNSHolding(s) in Company
2nd Feb 20218:00 amRNSAdmission of Nil Paid Rights
1st Feb 20214:05 pmRNSResults of Court Meeting and General Meeting
1st Feb 20213:55 pmRNSResult of General Meeting - Liquidnet Acquistion
29th Jan 20211:05 pmRNSPublication of Suppl.Prospcts
25th Jan 20217:00 amRNSUpdate on Brexit Readiness Plan

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.